Cargando…

Treatment of Idiosyncratic Drug-Induced Liver Injury Using Steroids

Idiosyncratic drug-induced liver injury (DILI), when severe, can be associated with significant morbidity and mortality. Currently, there are no specific therapies for DILI, apart from corticosteroids for drug-induced autoimmune hepatitis caused by drugs such as nitrofurantoin or minocycline. We pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundaram, Suneha, Vuppalanchi, Raj, Saxena, Romil, Chalasani, Naga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145177/ https://www.ncbi.nlm.nih.gov/pubmed/32309510 http://dx.doi.org/10.14309/crj.0000000000000319

Ejemplares similares

Progressive Cholestasis and Biliary Cirrhosis After Initiating Oral Semaglutide: Report From the Drug-Induced Liver Injury Network
por: Ma, Jiayi, et al.
Publicado: (2022)

Serum Hepcidin Levels Are Associated With Obesity but Not Liver Disease
por: Vuppalanchi, Raj, et al.
Publicado: (2013)

Idiosyncratic Liver Injury Due to Levocetirizine
por: Annunziata, Giuseppe, et al.
Publicado: (2019)

Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
por: Rakers, Florian, et al.
Publicado: (2023)

Immune mechanisms of idiosyncratic drug-induced liver injury
por: Mak, Alastair, et al.
Publicado: (2017)

Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury
por: Kim, Seung-Hyun, et al.
Publicado: (2016)

Idiosyncratic drug‐induced liver injury: A short review
por: Yamashita, Yo‐ichi, et al.
Publicado: (2017)

Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges
por: Jee, Alison, et al.
Publicado: (2021)

Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury
por: Ghabril, Marwan, et al.
Publicado: (2020)

Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver Injury
por: Krueger, Winfried, et al.
Publicado: (2014)

Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays
por: Roth, Alexander D., et al.
Publicado: (2017)

Metamizole: An underrated agent causing severe idiosyncratic drug‐induced liver injury
por: Sebode, Marcial, et al.
Publicado: (2020)

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues
por: Teschke, Rolf, et al.
Publicado: (2021)

Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report
por: Ladna, Michael, et al.
Publicado: (2023)

Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury
por: Xie, Zhongyang, et al.
Publicado: (2021)

Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation
por: Ngwa, Taiwo, et al.
Publicado: (2020)

Liver Injury and Fibrosis Induced by Dietary Challenge in the Ossabaw Miniature Swine
por: Liang, Tiebing, et al.
Publicado: (2015)

Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
por: Tolosa, Laia, et al.
Publicado: (2017)

An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children
por: Sandritter, Tracy L., et al.
Publicado: (2019)

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
por: Segovia-Zafra, Antonio, et al.
Publicado: (2021)

Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria
por: Ma, Christopher D., et al.
Publicado: (2022)

Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury
por: Gai, Zhibo, et al.
Publicado: (2023)

Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM
por: Andújar-Vera, Francisco, et al.
Publicado: (2023)

Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease
por: Yates, Katherine P., et al.
Publicado: (2017)

HIV-1 Coinfection Profoundly Alters Intrahepatic Chemokine but Not Inflammatory Cytokine Profiles in HCV-Infected Subjects
por: Hu, Sishun, et al.
Publicado: (2014)

Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature
por: Radovanovic, Milan, et al.
Publicado: (2018)

Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review
por: Robles-Díaz, Mercedes, et al.
Publicado: (2021)

Drug-Induced Idiosyncratic Agranulocytosis - Infrequent but Dangerous
por: Rattay, Bernd, et al.
Publicado: (2021)

Poria Attenuates Idiosyncratic Liver Injury Induced by Polygoni Multiflori Radix Praeparata
por: Gao, Dan, et al.
Publicado: (2016)

Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report
por: Moole, Harsha, et al.
Publicado: (2015)

Anagen Effluvium after Methotrexate: An Idiosyncratic Reaction
por: Sinha, Preema, et al.
Publicado: (2020)

Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies
por: Teschke, Rolf, et al.
Publicado: (2021)

Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
por: Niu, Hao, et al.
Publicado: (2022)

Intrahepatic infiltration of activated CD8(+) T cells and mononuclear phagocyte is associated with idiosyncratic drug-induced liver injury
por: Yang, Hyun, et al.
Publicado: (2023)

Idiosyncratic Drug-Induced Neutropenia and Agranulocytosis in Elderly Patients
por: Lorenzo-Villalba, Noel, et al.
Publicado: (2020)

Retrospective study of idiosyncratic drug-induced liver injury from infliximab in an inflammatory bowel disease cohort: the IDLE study
por: Worland, Thomas, et al.
Publicado: (2020)

The generation of HepG2 transmitochondrial cybrids to reveal the role of mitochondrial genotype in idiosyncratic drug-induced liver injury
por: Ball, Amy Louise, et al.
Publicado: (2023)

Corrigendum: Intrahepatic infiltration of activated CD8(+) T cells and mononuclear phagocyte is associated with idiosyncratic drug-induced liver injury
por: Yang, Hyun, et al.
Publicado: (2023)

Exploratory Study of Autoantibody Profiling in Drug‐Induced Liver Injury with an Autoimmune Phenotype
por: Lammert, Craig, et al.
Publicado: (2020)

Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
por: Teschke, Rolf, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_907aie9jl27uvirkqv1gp6v1kg